VCU researchers developing affordable, noninvasive treatment for RDS in newborns
Worth Longest (a well-known professor at TechTransfer and Ventures) and his team received a $3 million grant to create an aerosolized surfactant - a substance that lowers liquid surface tension - and a device to deliver it.